• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT G3+ CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT G3+ CARTRIDGE Back to Search Results
Catalog Number 03P78-25
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/26/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Apoc incident # (b)(4).Apoc labeling will be evaluated during the investigation as pertaining to the event.
 
Event or Problem Description
On (b)(6) 2021, abbott point of care was contacted by a customer regarding i-stat g3+ cartridges that yielded a suspected discrepant results on a patient.There was no patient information available at the time of this report.(b)(6).At this time there is no reason to suspect a malfunction exists.The reporting decision was based on limited information available that suggests the product was not performing within the variability of the assay.The customer states that sample was tested on another abg instrument (company name, model is not available) and staff is not willing to share report comparative instrument.The investigation is underway.
 
Additional Manufacturer Narrative
Apoc incident: # (b)(4).The investigation was completed on 27-sep-2021.The customer reported high unexpected po2 results when testing samples from a patient with g3+ cartridge lots n21110 and n21145.When all patient results were reviewed relative to total allowable error (ea) as per ts-6440 rev.R, i-stat cartridges, the pco2 and ph results were also identified as being potentially discrepant and will therefore be included in this investigation.A review of the device history records confirmed the lots passed finished goods release criteria.Retained cartridge testing for both lots met the acceptance criteria found in q04.01.003 rev.Ag, appendix 1- product complaint level 2 and level 3 investigation procedure.No deficiency has been identified.
 
Event or Problem Description
Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT G3+ CARTRIDGE
Common Device Name
G3+ CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton NJ 08540 6607
MDR Report Key12359265
Report Number2245578-2021-00069
Device Sequence Number19801840
Product Code CHL
UDI-Device Identifier10054749000064
UDI-Public10054749000064
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
K940918
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/22/2022
Device Catalogue Number03P78-25
Device Lot NumberN21145
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 08/02/2021
Supplement Date Received by Manufacturer09/27/2021
Initial Report FDA Received Date08/24/2021
Supplement Report FDA Received Date09/28/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-